|
      
   
|
Mark Alexay,
President & CEO
Mark Alexay, President & CEO, started his experience in
the pharmaceutical industry as a marketing manager for Pfizer
in the early 1990's. He managed anti-inflammatory, anti-bacterial,
and anti-hypertensive product lines and introduced Norvasc,
a successful once-a-day blood pressure-lowering drug.
He joined Strategic Research Institute, a New York-based start-up
conference company in 1994, pioneered and built the Life
Sciences Conference Division, and grew it until he left in early
2007. Mark conceived and organized over 100 successful
pharma and biotech conferences during his tenure and directed
the organization of many more. Mark holds a BA from
Denison University and a joint MIA/MBA from Columbia University.
|